These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1007 related items for PubMed ID: 22940857

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
    Niebler RA, Punzalan RC, Marchan M, Lankiewicz MW.
    Pediatr Crit Care Med; 2010 Jan; 11(1):98-102. PubMed ID: 19561557
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life.
    Northrop MS, Sidonio RF, Phillips SE, Smith AH, Daphne HC, Pietsch JB, Bridges BC.
    Pediatr Crit Care Med; 2015 Jan; 16(1):66-74. PubMed ID: 25319630
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality.
    Zabrocki LA, Brogan TV, Statler KD, Poss WB, Rollins MD, Bratton SL.
    Crit Care Med; 2011 Feb; 39(2):364-70. PubMed ID: 20959787
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with respiratory and heart failure: review of our experience.
    Goto T, Suzuki Y, Suzuki Y, Osanai A, Aoki K, Yamazaki A, Daitoku K, Fukuda I.
    Artif Organs; 2011 Nov; 35(11):1002-9. PubMed ID: 22097977
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin.
    Douglas AD, Jefferis J, Sharma R, Parker R, Handa A, Chantler J.
    Angiology; 2009 Nov; 60(3):358-61. PubMed ID: 19398428
    [Abstract] [Full Text] [Related]

  • 18. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study.
    Irby K, Swearingen C, Byrnes J, Bryant J, Prodhan P, Fiser R.
    Pediatr Crit Care Med; 2014 May; 15(4):e175-82. PubMed ID: 24622165
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist.
    Bein T, Zimmermann M, Philipp A, Ramming M, Sinner B, Schmid C, Müller T, Graf B, Schlitt HJ, Weber-Carstens S.
    ASAIO J; 2011 May; 57(3):164-8. PubMed ID: 21427564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.